In this newly created role, Peter will focus on building and leading a dedicated effort on investments in high-growth and profitable businesses.
“We are thrilled to welcome Peter to the McKesson Ventures team,” said Dave Schulte, President of McKesson Ventures. “We are proud to have one of the most comprehensive biopharma services investment portfolios in the industry and are excited to be able to partner with a broader range of founders and management teams who are building early to late-stage businesses. Peter’s extensive growth equity investing experience in biopharma services and life sciences tools is the perfect match for our expanded strategy.”
Most recently, Lafer served as a Principal at General Atlantic (GA), a global growth equity firm, where he worked in both the Healthcare and Life Sciences groups. Prior to his time at GA, he was an investor at EW Healthcare Partners and began his career as an analyst in the Healthcare Investment Banking group at J.P. Morgan. For more information on this story, view other related materials below.
See related materials: